National Secretary

Adebanjo Adegbola is a pharmaceutical scientist who studies drug dispositions and treatment outcomes, particularly in children and adult pregnant women. I obtained a PhD in Pharmaceuticcal Chemistry (Pharmacokinetics and Pharmacogenomics) in October 2018 from Obafemi Awolowo University in Ile-Ife, Nigeria, where I am employed as a lecturer in the Faculty of Pharmacy. I investigated the influence of pregnancy and genetic polymorphisms on the pharmacokinetics interaction between antimalarial medicines and antiretroviral drugs in my PhD project. Dr Adegbola has received a postdoctoral Fellowship funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). He is currently working on an efficacy study to investigate the impact of new mutations in the gene of dihydropteroate synthase on the protective effect of intermittent preventive treatment during pregnancy using sulphadoxine-pyrimethamine. 

Adebanjo Adegbola
NEWS ALERT... Conference Registration Members N10,000 Non-Members N15,000 Undergraduate Students N5,000 International Participants US$50 Registration Deadlines Early Birds Registration 30th June, 2022 Late Registration 1st July, 2022 attracts additional N10,000 Online participation is available at the same fee.